New insider activity at Madrigal Pharmaceuticals ( (MDGL) ) has taken place on March 8, 2025.
Robert E. Waltermire, the Senior Vice President and Chief Pharma Developer at Madrigal Pharmaceuticals, recently sold 14,113 shares of the company’s stock. This transaction amounted to a total value of $4,817,012.
More about Madrigal Pharmaceuticals
YTD Price Performance: 4.78%
Average Trading Volume: 406,508
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $7.67B
Questions or Comments about the article? Write to editor@tipranks.com